SCHEMBL23867470

SCHEMBL23867470

Cc1cc(Nc2ccc(NC(=O)Cc3c[nH]c4ccc(Br)cc34)cc2)nc(N2CCCC2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 2/20 0.44
▸ LMNA P02545 5/20 0.43
▸ MAPT P10636 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ SIGMAR1 Q99720 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ SLC2A1 P11166 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ HCRTR1 O43613 2/20 0.42
▸ HCRTR2 O43614 2/20 0.42
▸ ROCK2 O75116 3/20 0.42
▸ ROCK1 Q13464 1/20 0.40
▸ CCNE1 P24864 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867468 0.91 HRH3 (0.45) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867472 0.89 HRH3 (0.48) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867473 0.88 HCRTR1 (0.53) SIGMAR1SLC2A1KDM4EHPGDHCRTR1
SCHEMBL30234700 0.85 HRH3 (0.47) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867524 0.82 HCRTR1 (0.52) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL30979651 0.81 SLC2A1 (0.51) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL31094227 0.81 SLC2A1 (0.44) HRH3LMNAMAPTMEN1KMT2A
SCHEMBL23867576 0.78 LMNA (0.52) LMNAMAPTALDH1A1SLC2A1KDM4E
SCHEMBL31094238 0.77 SLC2A1 (0.50) LMNAMAPTALDH1A1SLC2A1KDM4E
SCHEMBL31094225 0.77 CCNE1 (0.49) LMNAMAPTALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021195279-A2 SMALL MOLECULE INHIBITORS OF ONCOGENIC CHD1L WITH PRECLINICAL ACTIVITY AGAINST COLORECTAL CANCER THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) 2021-09-30 — — WO disclosed
Send feedback